This trust offers the following services:

• Diagnostic and pre-operative services:
• On-site MRI liver facilities
• On-site PET-CT facilities
• Routine Genetic Testing for Lynch Syndrome

• Oncology services:
• On-site chemotherapy services

• Surgical services:
• On-site thoracic surgical team

• Advanced disease services:
• Dedicated Specialist Advanced MDT

• Support service facilities:
• Availability of 24 hour palliative care advice

All Patients:	Trust	Network	National
Number of patients in Audit	151	1245	29766
Case ascertainment (%)	88	87	90
Data completeness of:
– Pre-treatment TNM (%)	95	86	83
– Performance status (%)	91	97	85

Patients having major resection:	Trust	Network	National
Number of patients in Audit	N/A	720	16499
ASA grade 1 (%)	N/A	9	10
ASA grade 2 (%)	N/A	58	53
ASA grade 3 (%)	N/A	29	30
ASA grade 4+ (%)	N/A	2	3
ASA grade not recorded (%)	N/A	2	4
Data completeness of:
7 Audit items for risk-adjustment (%)	N/A	68	86

All Patients:	Trust	Network	National
Number of patients in Audit	151	1245	29766
Seen by Clinical Nurse Specialist (%)	99	94	86

All patients deemed potentially curative	Trust	Network	National
Number of potentially curative patients	34	324	7226
Undergoing major resection (%)	94	91	86

Patients having major resection:	Trust	Network	National
Number of patients in Audit	N/A	720	16474
Distant metastases (%)	N/A	6	6
Urgent or emergency surgery (%)	N/A	13	15
At least 12 lymph nodes excised (%)	N/A	68	84
Laparoscopic surgery attempted (%)	N/A	62	72
Risk-adjusted length of stay > 5 days (%)	N/A	72	62

Patients having major resection for stage III colon cancer:	Trust	Network	National
Number of patients in audit	24	470	10641
Adjuvant chemotherapy (%)	42	58	61

Patients having major resection:	Trust	Network	National
Number of patients in Audit	N/A	159	3899
Neoadjuvant therapy (%)	N/A	24	32
Circumferential resection margin: Recorded (%)	N/A	69	86
Circumferential resection margin: Negative (%)	N/A	62	79
Rectal volume	N/A	N/A	N/A

Patients in APER/Hartmanns estimate:	Trust	Network	National
Number of patients in APER/Hartmanns estimate	N/A	N/A	N/A
APER/Hartmanns (%)	N/A	N/A	N/A